Also published in gurufocus.com:
Morgan Stanley's Corporate Governance Could Improve
x hide permanently

Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors

gurufocus.com

LOS ANGELES, Jan. 25, 2018 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting Alzheimer's, diabetes, lupus and cancers, among other diseases, today announced the appointment ...

Mentions: Nasdaq Deborah Aghib Stellar Biotechnologies